Recorded on December 15th, 2022 as part of the Northwestern University Renal Grand Round, speaker Sylvia E. Rosas, MD, MSCE discusses the Role of Mineralocorticoid Receptor Antagonist in the treatment of Diabetic Kidney Disease.
_________________________________________________________________
About Dr. Rosas:
Sylvia E. Rosas, MD, MSCE is a nephrologist and epidemiologist at the Joslin Diabetes Center in Boston, Ma. She is the Director of the Latino Kidney Clinic and an Associate Professor of Medicine at Harvard Medical School. She is also a nephrologist at the Beth Israel Deaconess Medical Center.
Dr. Rosas completed medical school at University of Rosario in Bogotá, Colombia and Internal Medicine training at Michael Reese Hospital/University of Illinois at Chicago. She obtained Clinical Nephrology training, a Master’s in Clinical Epidemiology, as well as completed the Wharton Management Program from the University of Pennsylvania.
Dr. Rosas’s primary research focus is on the epidemiology of metabolic and cardiovascular disease complications in patients with chronic kidney disease (CKD) particularly diabetic kidney disease. In addition, she has evaluated health disparities in individuals with CKD, particularly in those of Hispanic/Latino background. She has contributed to our understanding of vascular calcification and cardiovascular screening tools in patients with CKD. She is a member of the Membership Committee of the Council on The Kidney in Cardiovascular Disease.
_________________________________________________________________
About NUGoKidney Northwestern University's George M. O'Brien Kidney Research Core Center provides data, tools, and resources to promote collaborative partnerships and propel the development of transformative therapeutics for patients with kidney diseases. Connect with NUGoKidney: Sign up for NUGoKidney email newsletter: bit.ly/NUGoKidn... Visit the NUGoKidney website: www.nephrohub.org/ Follow NUGoKidney on Twitter: / nu_nephrology Follow NUGoKidney on Instagram: / nu_nephrology
15 сен 2024
